Organogenesis Holdings (ORGO) Accounts Payables (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Accounts Payables of $28.6 million for Q1 2026, up 16.04% year-over-year from $24.7 million in Q1 2025, and down 10.44% quarter-over-quarter from $31.9 million in Q4 2025.
Organogenesis Holdings (ORGO) Accounts Payables (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Accounts Payables history runs 10 years deep, the most recent figure standing at $28.6 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 16.04% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $28.6 million (up 16.04% YoY), while the FY2025 annual figure was $31.9 million, up 10.51% from the prior year.
- Accounts Payables for Q1 2026 stood at $28.6 million, down from $31.9 million in the prior quarter.
- The five-year high for Accounts Payables was $40.2 million in Q3 2025, with the low at $23.2 million in Q1 2024.
- The 5-year median for Accounts Payables is $29.4 million (2024), against an average of $30.0 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables retreated 29.43% in 2023, then soared 67.78% in 2025.
- Organogenesis Holdings' Accounts Payables stood at $32.3 million in 2022, then retreated by 4.97% to $30.7 million in 2023, then decreased by 5.9% to $28.9 million in 2024, then climbed by 10.51% to $31.9 million in 2025, then dropped by 10.44% to $28.6 million in 2026.
- Business Quant data shows ORGO's Accounts Payables at $28.6 million in Q1 2026, $31.9 million in Q4 2025, and $40.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Organogenesis Holdings | 243.84 Mn | 196.99 Mn | 20.08 Mn | 29.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.29 Mn |
| Mar 31, 2026 | 28.62 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Sep 30, 2025 | 40.22 Mn |
| Jun 30, 2025 | 29.72 Mn |
| Mar 31, 2025 | 24.66 Mn |
| Dec 31, 2024 | 28.91 Mn |
| Sep 30, 2024 | 23.97 Mn |
| Jun 30, 2024 | 29.39 Mn |
| Mar 31, 2024 | 23.23 Mn |
| Dec 31, 2023 | 30.72 Mn |
| Sep 30, 2023 | 26.78 Mn |
| Jun 30, 2023 | 27.39 Mn |
| Mar 31, 2023 | 30.31 Mn |
| Dec 31, 2022 | 32.33 Mn |
| Sep 30, 2022 | 37.95 Mn |
| Jun 30, 2022 | 36.37 Mn |
| Mar 31, 2022 | 27.94 Mn |
| Dec 31, 2021 | 29.34 Mn |
| Sep 30, 2021 | 28.49 Mn |